Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Biberach

7 clinical trials in Biberach, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Biberach at a glance
7
clinical trials
  • Recruiting now0
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

7 trials in Biberach

Open in trial search

Drug level

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · Healthy volunteers
  • Substances:Itraconazole
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:GermanyGermany
  • Participants:18–64 years · Healthy volunteers
  • Sponsor:Boehringer Ingelheim International GmbH

Drug level

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · Healthy volunteers
  • Substances:Bi 685509
  • Sponsor:Boehringer Ingelheim International GmbH

Drug level

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · Healthy volunteers
  • Substances:Bi 1015550
  • Sponsor:Boehringer Ingelheim International GmbH

Drug level

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · Healthy volunteers
  • Substances:Itraconazole
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:GermanyGermany
  • Participants:18–64 years · Healthy volunteers
  • Substances:Bi 1015550
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:Universitaetsklinikum Ulm AöR

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Biberach

What the registry says about research in the country

01 Breast Cancer Research

Clinical trials focusing on hormone receptor-positive HER2-negative breast cancer, investigating innovative combination therapies for patients with locally advanced or metastatic disease.

  • Treatment Advancement
  • Digital Side Effect Management
  • Progression-Free Survival Assessment

Research evaluates the effectiveness of Abemaciclib combined with endocrine therapy, with special attention to patient monitoring through digital tools.

02 Therapeutic Innovation

Studies exploring targeted treatment approaches for different patient cohorts, including those with advanced metastatic breast cancer at various stages of endocrine treatment response.

  • Treatment-Naive Patients
  • Prior Therapy Response
  • Disease Progression Monitoring

The research aims to establish optimal treatment strategies based on individual patient treatment history and response patterns.

03 Clinical Outcomes

Comprehensive evaluation of progression-free survival in distinct patient populations, considering various treatment timelines and prior therapy experiences.

  • Response Assessment
  • Long-term Monitoring
  • Treatment Effectiveness

Research focuses on measuring treatment outcomes using standardized criteria and systematic patient follow-up protocols.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).